BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 27672278)

  • 61. Diagnosis of primary biliary cirrhosis.
    Hirschfield GM
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):701-12. PubMed ID: 22117636
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical significance of autoantibodies in primary biliary cirrhosis.
    Nakamura M
    Semin Liver Dis; 2014 Aug; 34(3):334-40. PubMed ID: 25057956
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinical and pathological characterization of the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis].
    Zhu GJ; Chen S; Mao Q; Wang YM
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):6-8. PubMed ID: 15670481
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Bonder A; Retana A; Winston DM; Leung J; Kaplan MM
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):609-12. PubMed ID: 21440668
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical correlations and significance of orceinpositivity in chronic active hepatitis and primary biliary cirrhosis.
    Salaspuro MP; Sipponen P; Ikkala E; Kolho L; Makkonen HM; Miettinen TA; Räsänen JA; Siurala M
    Ann Clin Res; 1976 Jun; 8(3):206-15. PubMed ID: 63265
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The clinical characteristics of primary biliary cirrhosis in China: a systematic review].
    Gu EL; Yao GB
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):861-6. PubMed ID: 19958649
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis.
    Juliusson G; Imam M; Björnsson ES; Talwalkar JA; Lindor KD
    Scand J Gastroenterol; 2016; 51(6):745-52. PubMed ID: 26776319
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical Features and Risk Factors for Drug-Induced Liver Injury: A Retrospective Study From China.
    Ma X; Chen Z; An J; Zhang C
    Clin Ther; 2024 May; ():. PubMed ID: 38821767
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Florid biliary duct lesions in an AMA -positive patient in absence of cholestatic liver biochemistry.
    Sultan K; Petkar M; Derbala M
    J Autoimmun; 2019 Jul; 101():153-155. PubMed ID: 30975574
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A spectrum of histopathologic findings in autoimmune liver disease.
    Terracciano LM; Patzina RA; Lehmann FS; Tornillo L; Cathomas G; Mhawech P; Vecchione R; Bianchi L
    Am J Clin Pathol; 2000 Nov; 114(5):705-11. PubMed ID: 11068543
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Canals of Hering loss relates to the progression of the histological stages of primary biliary cirrhosis.
    Kakuda Y; Harada K; Nakanuma Y
    J Clin Pathol; 2015 Feb; 68(2):141-7. PubMed ID: 25430494
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Laboratory tests for diagnosis of autoimmune diseases.
    Nakamura RM; Chisari FV; Edgington TS
    Prog Clin Pathol; 1975; 6():177-203. PubMed ID: 1105671
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis.
    Agmon-Levin N; Shapira Y; Selmi C; Barzilai O; Ram M; Szyper-Kravitz M; Sella S; Katz BS; Youinou P; Renaudineau Y; Larida B; Invernizzi P; Gershwin ME; Shoenfeld Y
    J Autoimmun; 2010 Feb; 34(1):55-8. PubMed ID: 19897339
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of M2 antibodies in asymptomatic Chinese population.
    Jiang XH; Zhong RQ; Fan XY; Hu Y; An F; Sun JW; Kong XT
    World J Gastroenterol; 2003 Sep; 9(9):2128-31. PubMed ID: 12970922
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis.
    Muratori P; Granito A; Ferri S; Pappas G; Volta U; Menichella R; Bianchi FB; Lenzi M; Muratori L
    Autoimmunity; 2009 Mar; 42(3):224-7. PubMed ID: 19301204
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Prevalence of antinuclear antibodies in primary biliary cirrhosis, with negative antimitochondrial antibodies].
    Antonio Olivera M; Zapata L; Kaplan M; Bobadilla J; Corte G; de la Mora G; Uribe M; Cabiedes J; Dehesa M; Kershenobich D
    Rev Gastroenterol Mex; 1993; 58(3):220-2. PubMed ID: 8165399
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Primary biliary cirrhosis in Lithuania: diagnosis and clinical picture.
    Speiciene D; Irnius A; Leuschner U; Liakina V; Semuchiniene T; Barakauskiene A
    Med Sci Monit; 2007 Jul; 13(7):CR299-306. PubMed ID: 17599023
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diagnosis and management of primary biliary cirrhosis.
    Ali AH; Carey EJ; Lindor KD
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group.
    Poupon R; Chazouillères O; Balkau B; Poupon RE
    J Hepatol; 1999 Mar; 30(3):408-12. PubMed ID: 10190722
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis.
    Taylor SL; Dean PJ; Riely CA
    Am J Surg Pathol; 1994 Jan; 18(1):91-9. PubMed ID: 8279631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.